Health Matters
Printing is not available for Health Matters content.
Subscribers can read every article in full at health-matters.io.

Johnson & Johnson

04.09.2024

South Africa's fight against AIDS and TB spotlights battles over high drug costs, patent monopolies, and the power of activism in securing affordable medicines for all.

08.07.2024

Following an agreement with the Competition Commission, J&J will not enforce its TB drug patent in 134 countries and will reduce the drug price in South Africa.

Search the archive

Browse by month